PartsTable
Technical Data Sheet
Download PDF

NDC51309-0235-02 — METOCLOPRAMIDE INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC51309-0235-02: METOCLOPRAMIDE INJECTION.

The METOCLOPRAMIDE INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAMUSCULAR OR INTRAVENOUS, primary_container_type: AMPUL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 25, primary_container_content_quantity: 2.000 MILLILITERS, active_medicament_medicinal_strength: 5.000 MILLIGRAMS METOCLOPRAMIDE EQUIVALENT PER MILLILITER. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-123-4726, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC51309-0235-02
NSN: 6505-01-123-4726
FSC: 6505 — Drugs and Biologicals
CAGE: 42276 — QUAD PHARMACEUTICALS INC (USA)
SPECIFICATIONS
administrationINTRAMUSCULAR OR INTRAVENOUS
primary_container_typeAMPUL
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
total_primary_container_quantity25
primary_container_content_quantity2.000 MILLILITERS
active_medicament_medicinal_strength5.000 MILLIGRAMS METOCLOPRAMIDE EQUIVALENT PER MILLILITER
NSN6505-01-123-4726
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available METOCLOPRAMIDE INJECTION TITLE COMPONENT PN NDC51309-0235-02 MFR METOCLOPRAMIDE INJECTI
KEY FEATURES
•
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
•
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
PRIMARY CONTAINER TYPE: AMPUL
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METOCLOPRAMIDE EQUIVALENT PER MILLILITER
•
TOTAL PRIMARY CONTAINER QUANTITY: 25
TECHNICAL CHARACTERISTICS
ADMINISTRATIONINTRAMUSCULAR OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY2.000 MILLILITERS
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPEAMPUL
ACTIVE MEDICAMENT MEDICINAL STRENGTH5.000 MILLIGRAMS METOCLOPRAMIDE EQUIVALENT PER MILLILITER
TOTAL PRIMARY CONTAINER QUANTITY25
SUBSTITUTES & CROSS-REFERENCES 1
REGLANReference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy NDC51309-0235-02?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC51309-0235-02?
NDC51309-0235-02 is a METOCLOPRAMIDE INJECTION.
What parts can replace NDC51309-0235-02?
There is 1 known substitute for NDC51309-0235-02: REGLAN. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC51309-0235-02?
NDC51309-0235-02 is cataloged in the U.S. Government catalog under NSN 6505-01-123-4726. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC51309-0235-02